ArticleJournal of assisted reproduction and genetics2026
2,000 IU hCG is the optimal dose in a dual hCG/GnRH agonist trigger to achieve comparable pregnancy rates to hCG alone in fresh embryo transfers.
Article in Journal of assisted reproduction and genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo determine the optimal hCG dose in a dual hCG/GnRH agonist trigger for comparable pregnancy outcomes to hCG, while maintaining low OHSS rates in good-prognosis patients. SUBJECTS: This retrospective cohort study included patients aged 18-41 years undergoing IVF or IVF/ICSI with fresh embryo transfer from 2013 to 2024. Patients received either hCG-only (5,000-10,000 IU hCG/250-500 mcg Ovidrel) or dual trigger (1,500-2,000 IU hCG + 2 mg GnRH agonist).
resultsA total of 2641 cycles were analyzed (1,939 hCG-only, 616 1,500 IU hCG dual trigger, and 86 2,000 IU hCG dual trigger). The 2,000 IU hCG dual trigger group yielded more mature oocytes (16.0 vs. 11.6, aRR 1.29), fertilized embryos (12.9 vs. 8.8, aRR 1.43), and blastocysts (8.0 vs. 4.9, aRR 1.55) than hCG-only. Implantation rates were higher with 2,000 IU hCG dual trigger than hCG-only (50.0% vs. 32.0%, RR 1.56), with a dose-dependent improvement within the dual trigger groups (50.0% at 2,000 IU vs. 36.4% at 1,500 IU, RR 1.37). Ongoing pregnancy rates were similar between 2,000 IU hCG dual trigger and hCG-only (46.8% vs. 39.5%, aRR 1.12), but lower with 1,500 IU hCG dual trigger (46.8% vs. 37.6%, aRR 1.37). OHSS rates were low across all groups.
conclusion2,000 IU hCG appears to be the optimal dose in a dual hCG/GnRH agonist trigger, resulting in similar pregnancy outcomes to an hCG trigger and low rates of OHSS among good-responder patients. Ongoing pregnancy rates were significantly lower with hCG doses under 2,000 IU in the dual trigger protocol.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.